Caption Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Caption Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-45,000	Closed	-$907K	–	2092
2021 Q3	$907K	Buy	45,000 +15,000	+50%	+$414K	0.01%	1049
2021 Q2	$1.12M	Hold	30,000	–	–	0.01%	861
2021 Q1	$767K	Hold	30,000	–	–	0.02%	730
2020 Q4	$661K	Buy	30,000 +20,000	+200%	+$441K	0.02%	688
2020 Q3	$180K	Hold	10,000	–	–	﹤0.01%	914
2020 Q2	$254K	Buy	+10,000	New	+$215K	0.01%	775

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Caption Management's DRNA Position: Q4 2021 in Review

Caption Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 37,443 shares — an estimated $755K sold.

Caption Management first reported a position in DRNA in Q3 2020 and held it in 2 quarters. The position peaked at $755K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Caption Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Caption Management sold 37,443 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $755K.
Caption Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2020 and held it in 2 quarters.
Caption Management's Dicerna Pharmaceuticals, Inc. position peaked at $755K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.